Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
Actinium Pharmaceuticals appointed Matt David, M.D. as Chief Financial Officer and principal financial officer, leading finance, accounting, capital markets and investor relations. Dr. David joins from CorMedix, where he served as CFO and later Chief Business Officer through FDA approval of DefenCath, its commercial launch, and a 2025 acquisition.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.